Cardiovascular Diseases Clinical Trial
— HEALOfficial title:
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
The purpose of this study is to examine how the environment and neighborhood characteristics affects the health of the area residents. The study will help determine how changing neighborhood characteristics, such as green space, affect heart health, risk factors for other diseases, sense of well- being or neighborhood cohesion.
Status | Recruiting |
Enrollment | 835 |
Est. completion date | October 30, 2026 |
Est. primary completion date | October 1, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 30 Years to 70 Years |
Eligibility | Inclusion Criteria: - 30-70 years of age. - Live within the targeted study location Exclusion Criteria: - Unwilling or unable to provide consent. - HIV/AIDS, active treatment for cancer, active bleeding including wounds. - Body weight less than 100 pounds or BMI>40. - Prisoners and other vulnerable populations. - Anyone that PI thinks is unsafe to participate in study. |
Country | Name | City | State |
---|---|---|---|
United States | University of Louisville | Louisville | Kentucky |
Lead Sponsor | Collaborator |
---|---|
University of Louisville | National Institute of Environmental Health Sciences (NIEHS), The Nature Conservancy |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cardiovascular Measurements. Change from Baseline Systolic and Diastolic pressures at baseline and 2 year followup. | Blood pressure mm Hg | Baseline and 2 year followup | |
Secondary | Pulse Wave Analysis. Assess change from baseline arterial stiffness measurement and 2 year followup. | Augmentation index-percent | Baseline and 2 year followup | |
Secondary | Physical Exam | Body weight-pounds | Baseline and 2 year followup | |
Secondary | Body lean mass | Body lean mass to be measured in pounds | Baseline and 2 year followup | |
Secondary | Body fat | Body fat to be measured in percentage | Baseline and 2 year followup | |
Secondary | Standing height | standing height reported in inches | Baseline and 2 year followup | |
Secondary | Waist, Hip measurement | central adiposity (waist circumference, and hip circumference to be measured in inches | Baseline and 2 year followup | |
Secondary | Respiratory status will be evaluated | Fleisch-type pneumotachometer used to evaluate FEV1 and FVC percentages | Baseline and 2 year followup | |
Secondary | Bucchal swab | Assess oral microbiome and DNA from cheek swab will be stored for genetic phenotyping. | Baseline and 2 year followup | |
Secondary | Urine collection | metabolites of environmental volatile organic compounds ng/mg creatinine, biogenic VOCs and nicotine metabolites ng/mg creatinine, catecholamines ng/mg creatinine | Baseline and 2 year followup | |
Secondary | Lipids | LDL-mg/dl, HDL-mg/dl, total cholesterol-mg/dl | Baseline and 2 year followup | |
Secondary | Toenail samples | Toenail samples to look for heavy metal exposure | Baseline and 2 year followup | |
Secondary | Hair samples | Hair samples to look at cortisol levels over time. | Baseline and 2 year followup | |
Secondary | Perceived stress scale-PSS-10 range 0-40 | The higher the score the more perceived stress | Baseline and 2 year followup | |
Secondary | Depression-Patient Health Questionnaire (PHQ-9) 0-27 | The 0-4= none; 5-9= Mild, 10-14= Moderate; 15-19= moderately severe; 20-27= severe. The higher the score the more severe the depression. | Baseline and 2 year followup | |
Secondary | Well-being assessment-Questionnaire 13-65 | Warwick-Edinburgh Mental Well-being scale 13-65. The higher the score the higher the sense of well-being. | Baseline and 2 year followup | |
Secondary | Health perception | Health perception questionnaire | Baseline and 2 year followup | |
Secondary | National Health Interview Survey tobacco questionnaire | National Health Interview Survey tobacco questionnaire | Baseline and 2 year followup | |
Secondary | The Alcohol Use disorders identification test (AUDIT)- Range 0-40 | Scores of 8-15 or more are recommended indicators of hazardous and harmful alcohol use or possible alcohol dependence. Women can be lowered to a score of 7 for concern. Scores of 16-19 suggest a need for brief counseling and continues monitoring. Scores of 20 or above warrant diagnostic evaluation for alcohol dependence. | Baseline and 2 year followup | |
Secondary | Self reported physical activity 1 | times per week | Baseline and 2 year followup | |
Secondary | Self reported physical activity 2 | Exertion level of mild moderate or vigorous | Baseline and 2 year followup | |
Secondary | Self reported education | Education to be reported by last school grade completed | Baseline and 2 year followup | |
Secondary | Self reported annual income | Annual income reported by dollars | Baseline and 2 year followup | |
Secondary | Platelet count | cells/cubic millimeter | Baseline and 2 year followup | |
Secondary | Complete Blood Count 1 | White/Red blood cell count- cells per cubic millimeter | Baseline and 2 year followup | |
Secondary | Complete Blood Count 2 | Hemoglobin-grams/deciliter | Baseline and 2 year followup | |
Secondary | Complete Blood Count 3 | Hematocrit-percentage | Baseline and 2 year followup | |
Secondary | Liver function | AST, ALT units per liter | Baseline and 2 year followup | |
Secondary | C-Reactive Protein | Hs-CRP-mg/Liter | Baseline and 2 year followup |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|